×

Chemed Cash Flow from Investing Activities 2010-2025 | CHE

Chemed annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2025. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • Chemed cash flow from investing activities for the quarter ending March 31, 2025 was $-0.144B, a 137.31% increase year-over-year.
  • Chemed cash flow from investing activities for the twelve months ending March 31, 2025 was $-0.408B, a 154.47% increase year-over-year.
  • Chemed annual cash flow from investing activities for 2024 was $-0.144B, a 137.31% increase from 2023.
  • Chemed annual cash flow from investing activities for 2023 was $-0.061B, a 2.09% increase from 2022.
  • Chemed annual cash flow from investing activities for 2022 was $-0.059B, a 2.85% increase from 2021.
Chemed Annual Cash Flow Investing
(Millions of US $)
2024 $-144
2023 $-61
2022 $-59
2021 $-58
2020 $-62
2019 $-191
2018 $-105
2017 $-68
2016 $-40
2015 $-50
2014 $-44
2013 $-31
2012 $-41
2011 $-34
2010 $-36
2009 $-23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.501B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.282B 18.36
DaVita (DVA) United States $11.202B 14.29
Encompass Health (EHC) United States $10.408B 23.33
Option Care Health (OPCH) United States $5.259B 25.21
Elanco Animal Health (ELAN) United States $4.190B 9.27
RadNet (RDNT) United States $3.686B 79.02
Amedisys (AMED) United States $3.011B 21.29
LifeStance Health (LFST) United States $2.576B 0.00
Addus HomeCare (ADUS) United States $1.840B 21.32
Astrana Health (ASTH) United States $1.573B 35.26
U.S Physical Therapy (USPH) United States $1.025B 26.14
Pennant (PNTG) United States $0.907B 36.29
Aveanna Healthcare Holdings (AVAH) United States $0.886B 0.00
Atai Life Sciences (ATAI) Germany $0.294B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00